Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

NCT07314164 · clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Ipsen